West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)
Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%
West Pharmaceutical Services price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
West Pharmaceutical Services's price to sales ratio was 8.7× on Nov 11, 2026, against 6.6× a year earlier. Over the last 5 years it ranged from 5.2× to 13.0×, with a median of 7.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.7× | +2.2 |
| 2025 | Dec 31, 2025 | 6.6× | −1.7 |
| 2024 | Dec 31, 2024 | 8.3× | −0.6 |
| 2023 | Dec 29, 2023 | 8.9× | +2.9 |
| 2022 | Dec 30, 2022 | 6.0× | −7.0 |
| 2021 | Dec 31, 2021 | 13.0× | +2.7 |
| 2020 | Dec 31, 2020 | 10.3× | +4.1 |
| 2019 | Dec 31, 2019 | 6.2× | +2.0 |
| 2018 | Dec 31, 2018 | 4.2× | −0.4 |
| 2017 | Dec 29, 2017 | 4.7× | +0.5 |
| 2016 | Dec 30, 2016 | 4.2× | +1.1 |
| 2015 | Dec 31, 2015 | 3.1× | +0.4 |
| 2014 | Dec 31, 2014 | 2.7× | +0.1 |
| 2013 | Dec 31, 2013 | 2.5× | +0.9 |
| 2012 | Dec 31, 2012 | 1.6× | +0.4 |
| 2011 | Dec 30, 2011 | 1.2× | −0.2 |
| 2010 | Dec 31, 2010 | 1.3× | −0.0 |
| 2009 | Dec 31, 2009 | 1.3× | – |
See a number that looks wrong?